“AI-Based Virtual Screening of NLRP3 Inflammasome-Targeting Drug Candidates for Alzheimer’s Disease and Evaluation of Blood–Brain Barrier Permeability”. Explore Medical Science and Global Health 3 (October 29, 2026): 38–47. Accessed October 31, 2026. https://journals.zeuspress.org/index.php/EMSGH/article/view/1628.